Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Muskelklinikken ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8%   Bankruptcy risk   2.6% 3.0% 4.0% 4.2% 3.6% 3.2% 18.9% 18.6%   Credit score (0-100)   63 59 49 47 52 55 7 7   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,313 1,101 605 662 527 482 0.0 0.0   EBITDA   406 352 292 301 184 110 0.0 0.0   EBIT   381 322 264 280 170 103 0.0 0.0   Pre-tax profit (PTP)   387.8 316.7 260.3 273.8 170.8 105.8 0.0 0.0   Net earnings   303.2 245.1 200.8 205.3 120.0 77.5 0.0 0.0   Pre-tax profit without non-rec. items   388 317 260 274 171 106 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   84.3 69.8 42.0 21.7 8.2 1.3 0.0 0.0   Shareholders equity total   396 341 292 302 272 175 44.7 44.7   Interest-bearing liabilities   7.7 0.4 11.4 1.0 2.4 21.8 0.0 0.0   Balance sheet total (assets)   535 486 400 360 314 276 44.7 44.7   Net Debt   -68.6 -79.7 -26.7 -107 -147 -62.6 -44.7 -44.7     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,313 1,101 605 662 527 482 0.0 0.0   Gross profit growth   13.9% -16.1% -45.1% 9.5% -20.5% -8.5% -100.0% 0.0%   Employees   0 0 0 0 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   535 486 400 360 314 276 45 45   Balance sheet change%   -20.1% -9.2% -17.6% -10.0% -12.6% -12.2% -83.8% 0.0%   Added value   406.0 352.4 292.1 300.7 190.4 110.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -28 -45 -56 -41 -27 -14 -1 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   29.0% 29.2% 43.7% 42.3% 32.3% 21.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   65.6% 64.4% 60.9% 74.1% 50.8% 35.9% 0.0% 0.0%   ROI %   91.9% 85.0% 80.2% 92.8% 59.3% 45.0% 0.0% 0.0%   ROE %   72.3% 66.5% 63.4% 69.1% 41.8% 34.7% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   74.0% 70.3% 73.0% 84.0% 86.6% 63.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -16.9% -22.6% -9.1% -35.6% -79.9% -56.8% 0.0% 0.0%   Gearing %   1.9% 0.1% 3.9% 0.3% 0.9% 12.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   70.2% 296.2% 159.0% 125.0% 27.6% 2.3% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   2.9 3.1 2.8 4.8 5.8 3.2 0.0 0.0   Current Ratio   2.9 3.1 2.8 4.8 5.8 3.2 0.0 0.0   Cash and cash equivalent   76.3 80.1 38.1 108.0 149.1 84.3 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   262.0 243.4 192.7 220.4 202.0 146.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 190 110 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 184 110 0 0   EBIT / employee   0 0 0 0 170 103 0 0   Net earnings / employee   0 0 0 0 120 77 0 0